Emerging nanocatalytic tumor therapies based on nontoxic but catalytically active inorganic
nanoparticles (NPs) for intratumoral production of high‐toxic reactive oxygen species have …

Catalytic nanozyme-based tumor therapy is currently considered as a promising strategy in
anti-tumor treatment, but it also has some disadvantages such as systemic toxicity, off-target …

Tumor cells metabolize in distinct pathways compared with most normal tissue cells. The
resulting tumor microenvironment would provide characteristic physiochemical conditions …

Designing nanozyme hybrids with cascade catalytic activities and coupling effects has
significant promises in tumor therapy through concerted effects. In this work, a goethite …

Nanocatalytic therapy, using artificial nanoscale enzyme mimics (nanozymes), is an
emerging technology for therapeutic treatment of various malignant tumors. However, the …

Artificial-engineered nanozymes show great promise for improving cancer therapeutic
outcomes. Herein, we elaborately designed the advanced cobalt-ferrite layered double …

Enzyme-mediated activation of prodrug in tumor cells is an attractive strategy for targeted
cancer therapy. Of note, natural peroxidase and indole-3-acetic acid (IAA) have been shown …

Currently, reactive oxygen species (ROS)-induced apoptosis systems have drawn
increasing attention in cancer therapy, owing to their specific tumor inhibition ability and …

The tumor microenvironment (TME) responsive multimodal theranostic nanoplatforms have
attracted great attentions for precision medicine. To design well-defined cascade catalytic …

Nanocatalytic therapy, involving the nanozyme‐triggered production of reactive oxygen
species (ROS) in the tumor microenvironment (TME), has demonstrated potential in tumor …